Cytokine therapy not recommended for metastatic RCC of intermediate prognosis. Comment
Publication
, Journal Article
Dahm, P; Moul, JW
Published in: Oncology Report
September 1, 2005
Duke Scholars
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2005
Issue
FALL
Start / End Page
64
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Dahm, P., & Moul, J. W. (2005). Cytokine therapy not recommended for metastatic RCC of intermediate prognosis. Comment. Oncology Report, (FALL), 64.
Dahm, P., and J. W. Moul. “Cytokine therapy not recommended for metastatic RCC of intermediate prognosis. Comment.” Oncology Report, no. FALL (September 1, 2005): 64.
Dahm P, Moul JW. Cytokine therapy not recommended for metastatic RCC of intermediate prognosis. Comment. Oncology Report. 2005 Sep 1;(FALL):64.
Dahm, P., and J. W. Moul. “Cytokine therapy not recommended for metastatic RCC of intermediate prognosis. Comment.” Oncology Report, no. FALL, Sept. 2005, p. 64.
Dahm P, Moul JW. Cytokine therapy not recommended for metastatic RCC of intermediate prognosis. Comment. Oncology Report. 2005 Sep 1;(FALL):64.
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2005
Issue
FALL
Start / End Page
64
Related Subject Headings
- Oncology & Carcinogenesis